Top compounds associated with response to LIPG


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.7
mRNA Rapamycin gCSI pan-cancer AAC -0.022 0.7
mRNA Zebularine CTRPv2 pan-cancer AAC -0.012 0.7
mRNA 5-FU CTRPv2 pan-cancer AAC -0.012 0.7
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.012 0.7
mRNA QL-X-138 GDSC1000 pan-cancer AAC 0.01 0.7
mRNA ceranib-2 CTRPv2 pan-cancer AAC -0.011 0.7
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.012 0.7
mRNA parbendazole CTRPv2 pan-cancer AAC 0.01 0.7
mRNA FMK GDSC1000 pan-cancer AAC 0.012 0.7
Download CSV